Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Gilead receives FDA complete response letters for elvitegravir and cobicistat

April 30, 2013

Japan Tobacco subsidiary set to launch novel anti-HIV combination tablet in Japan

April 25, 2013

Preclinical data reported for a novel HIV integrase inhibitor

April 15, 2013

Theratechnologies and Ferrer end tesamorelin agreement

April 9, 2013

Ferumoxytol-enhanced MRI shows potential for neuroimaging of patients with HAND

April 8, 2013

Stribild combination tablets approved in Japan

April 3, 2013

Bristol-Myers Squibb presents new series of anti-HIV agents

March 27, 2013

Small-molecule antiviral agents target HIV-1 replication

March 27, 2013

Stribild gets positive opinion in Europe

March 25, 2013

Biotron announces preliminary results from human trial of BIT-225

March 21, 2013

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...